 | • レポートコード：MRC2-11QY03987 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はNGSベース診断のグローバル市場について調査・分析したレポートです。種類別（DNAシーケンシング、RNAシーケンシング、全ゲノムシーケンシング、全エクソームシーケンシング、その他）市場規模、用途別（病院、診療所、学術・研究機関）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別NGSベース診断の競争状況、市場シェア ・世界のNGSベース診断市場：種類別市場規模 2015年-2020年（DNAシーケンシング、RNAシーケンシング、全ゲノムシーケンシング、全エクソームシーケンシング、その他） ・世界のNGSベース診断市場：種類別市場規模予測 2021年-2026年（DNAシーケンシング、RNAシーケンシング、全ゲノムシーケンシング、全エクソームシーケンシング、その他） ・世界のNGSベース診断市場：用途別市場規模 2015年-2020年（病院、診療所、学術・研究機関） ・世界のNGSベース診断市場：用途別市場規模予測 2021年-2026年（病院、診療所、学術・研究機関） ・北米のNGSベース診断市場分析：米国、カナダ ・ヨーロッパのNGSベース診断市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのNGSベース診断市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のNGSベース診断市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのNGSベース診断市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Janssen、Roche、Qiagen、ThermoFisher Scientific、Oxford Gene Technology、Illumina、Pacific Biosciences、Paradigm Diagnostics、Innogene Kalbiotech、Admera Health、AITbiotech、Centogene、Phalanx Biotech Group、iGenomX ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Next generation sequencing (NGS) based diagnostics are the medical devices used for diagnosis of various conditions using advanced generation sequencing platforms.
North America is currently leading the market due to the research and innovations and presence of maximum numbers of players. Europe is following America. Rising caseload of cancer, incidence of drug-resistant infectious diseases in Asian and African countries have created a huge demand of such technologies. Hence, market will grow at a fast pace in these regions.
Market Analysis and Insights: Global NGS Based Diagnostics Market
The global NGS Based Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global NGS Based Diagnostics Scope and Market Size
NGS Based Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global NGS Based Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Janssen
Roche
Qiagen
ThermoFisher Scientific
Oxford Gene Technology
Illumina
Pacific Biosciences
Paradigm Diagnostics
Innogene Kalbiotech
Admera Health
AITbiotech
Centogene
Phalanx Biotech Group
iGenomX
Market segment by Type, the product can be split into
DNA Sequencing
RNA Sequencing
Whole Genome Sequencing
Whole Exome Sequencing
Other
Market segment by Application, split into
Hospitals
Clinics
Academics/Research Institutions
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by NGS Based Diagnostics Revenue
1.4 Market by Type
1.4.1 Global NGS Based Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 DNA Sequencing
1.4.3 RNA Sequencing
1.4.4 Whole Genome Sequencing
1.4.5 Whole Exome Sequencing
1.4.6 Other
1.5 Market by Application
1.5.1 Global NGS Based Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Academics/Research Institutions
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global NGS Based Diagnostics Market Perspective (2015-2026)
2.2 Global NGS Based Diagnostics Growth Trends by Regions
2.2.1 NGS Based Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 NGS Based Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 NGS Based Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 NGS Based Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key NGS Based Diagnostics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top NGS Based Diagnostics Players by Market Size
3.1.1 Global Top NGS Based Diagnostics Players by Revenue (2015-2020)
3.1.2 Global NGS Based Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global NGS Based Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global NGS Based Diagnostics Market Concentration Ratio
3.2.1 Global NGS Based Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by NGS Based Diagnostics Revenue in 2019
3.3 NGS Based Diagnostics Key Players Head office and Area Served
3.4 Key Players NGS Based Diagnostics Product Solution and Service
3.5 Date of Enter into NGS Based Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global NGS Based Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global NGS Based Diagnostics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global NGS Based Diagnostics Market Size by Application (2015-2020)
5.2 Global NGS Based Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America NGS Based Diagnostics Market Size (2015-2020)
6.2 NGS Based Diagnostics Key Players in North America (2019-2020)
6.3 North America NGS Based Diagnostics Market Size by Type (2015-2020)
6.4 North America NGS Based Diagnostics Market Size by Application (2015-2020)
7 Europe
7.1 Europe NGS Based Diagnostics Market Size (2015-2020)
7.2 NGS Based Diagnostics Key Players in Europe (2019-2020)
7.3 Europe NGS Based Diagnostics Market Size by Type (2015-2020)
7.4 Europe NGS Based Diagnostics Market Size by Application (2015-2020)
8 China
8.1 China NGS Based Diagnostics Market Size (2015-2020)
8.2 NGS Based Diagnostics Key Players in China (2019-2020)
8.3 China NGS Based Diagnostics Market Size by Type (2015-2020)
8.4 China NGS Based Diagnostics Market Size by Application (2015-2020)
9 Japan
9.1 Japan NGS Based Diagnostics Market Size (2015-2020)
9.2 NGS Based Diagnostics Key Players in Japan (2019-2020)
9.3 Japan NGS Based Diagnostics Market Size by Type (2015-2020)
9.4 Japan NGS Based Diagnostics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia NGS Based Diagnostics Market Size (2015-2020)
10.2 NGS Based Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia NGS Based Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia NGS Based Diagnostics Market Size by Application (2015-2020)
11 India
11.1 India NGS Based Diagnostics Market Size (2015-2020)
11.2 NGS Based Diagnostics Key Players in India (2019-2020)
11.3 India NGS Based Diagnostics Market Size by Type (2015-2020)
11.4 India NGS Based Diagnostics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America NGS Based Diagnostics Market Size (2015-2020)
12.2 NGS Based Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America NGS Based Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America NGS Based Diagnostics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Janssen
13.1.1 Janssen Company Details
13.1.2 Janssen Business Overview
13.1.3 Janssen NGS Based Diagnostics Introduction
13.1.4 Janssen Revenue in NGS Based Diagnostics Business (2015-2020))
13.1.5 Janssen Recent Development
13.2 Roche
13.2.1 Roche Company Details
13.2.2 Roche Business Overview
13.2.3 Roche NGS Based Diagnostics Introduction
13.2.4 Roche Revenue in NGS Based Diagnostics Business (2015-2020)
13.2.5 Roche Recent Development
13.3 Qiagen
13.3.1 Qiagen Company Details
13.3.2 Qiagen Business Overview
13.3.3 Qiagen NGS Based Diagnostics Introduction
13.3.4 Qiagen Revenue in NGS Based Diagnostics Business (2015-2020)
13.3.5 Qiagen Recent Development
13.4 ThermoFisher Scientific
13.4.1 ThermoFisher Scientific Company Details
13.4.2 ThermoFisher Scientific Business Overview
13.4.3 ThermoFisher Scientific NGS Based Diagnostics Introduction
13.4.4 ThermoFisher Scientific Revenue in NGS Based Diagnostics Business (2015-2020)
13.4.5 ThermoFisher Scientific Recent Development
13.5 Oxford Gene Technology
13.5.1 Oxford Gene Technology Company Details
13.5.2 Oxford Gene Technology Business Overview
13.5.3 Oxford Gene Technology NGS Based Diagnostics Introduction
13.5.4 Oxford Gene Technology Revenue in NGS Based Diagnostics Business (2015-2020)
13.5.5 Oxford Gene Technology Recent Development
13.6 Illumina
13.6.1 Illumina Company Details
13.6.2 Illumina Business Overview
13.6.3 Illumina NGS Based Diagnostics Introduction
13.6.4 Illumina Revenue in NGS Based Diagnostics Business (2015-2020)
13.6.5 Illumina Recent Development
13.7 Pacific Biosciences
13.7.1 Pacific Biosciences Company Details
13.7.2 Pacific Biosciences Business Overview
13.7.3 Pacific Biosciences NGS Based Diagnostics Introduction
13.7.4 Pacific Biosciences Revenue in NGS Based Diagnostics Business (2015-2020)
13.7.5 Pacific Biosciences Recent Development
13.8 Paradigm Diagnostics
13.8.1 Paradigm Diagnostics Company Details
13.8.2 Paradigm Diagnostics Business Overview
13.8.3 Paradigm Diagnostics NGS Based Diagnostics Introduction
13.8.4 Paradigm Diagnostics Revenue in NGS Based Diagnostics Business (2015-2020)
13.8.5 Paradigm Diagnostics Recent Development
13.9 Innogene Kalbiotech
13.9.1 Innogene Kalbiotech Company Details
13.9.2 Innogene Kalbiotech Business Overview
13.9.3 Innogene Kalbiotech NGS Based Diagnostics Introduction
13.9.4 Innogene Kalbiotech Revenue in NGS Based Diagnostics Business (2015-2020)
13.9.5 Innogene Kalbiotech Recent Development
13.10 Admera Health
13.10.1 Admera Health Company Details
13.10.2 Admera Health Business Overview
13.10.3 Admera Health NGS Based Diagnostics Introduction
13.10.4 Admera Health Revenue in NGS Based Diagnostics Business (2015-2020)
13.10.5 Admera Health Recent Development
13.11 AITbiotech
10.11.1 AITbiotech Company Details
10.11.2 AITbiotech Business Overview
10.11.3 AITbiotech NGS Based Diagnostics Introduction
10.11.4 AITbiotech Revenue in NGS Based Diagnostics Business (2015-2020)
10.11.5 AITbiotech Recent Development
13.12 Centogene
10.12.1 Centogene Company Details
10.12.2 Centogene Business Overview
10.12.3 Centogene NGS Based Diagnostics Introduction
10.12.4 Centogene Revenue in NGS Based Diagnostics Business (2015-2020)
10.12.5 Centogene Recent Development
13.13 Phalanx Biotech Group
10.13.1 Phalanx Biotech Group Company Details
10.13.2 Phalanx Biotech Group Business Overview
10.13.3 Phalanx Biotech Group NGS Based Diagnostics Introduction
10.13.4 Phalanx Biotech Group Revenue in NGS Based Diagnostics Business (2015-2020)
10.13.5 Phalanx Biotech Group Recent Development
13.14 iGenomX
10.14.1 iGenomX Company Details
10.14.2 iGenomX Business Overview
10.14.3 iGenomX NGS Based Diagnostics Introduction
10.14.4 iGenomX Revenue in NGS Based Diagnostics Business (2015-2020)
10.14.5 iGenomX Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. NGS Based Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by NGS Based Diagnostics Revenue
Table 3. Ranking of Global Top NGS Based Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global NGS Based Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of DNA Sequencing
Table 6. Key Players of RNA Sequencing
Table 7. Key Players of Whole Genome Sequencing
Table 8. Key Players of Whole Exome Sequencing
Table 9. Key Players of Other
Table 10. Global NGS Based Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global NGS Based Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global NGS Based Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global NGS Based Diagnostics Market Share by Regions (2015-2020)
Table 14. Global NGS Based Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global NGS Based Diagnostics Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. NGS Based Diagnostics Market Growth Strategy
Table 20. Main Points Interviewed from Key NGS Based Diagnostics Players
Table 21. Global NGS Based Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 22. Global NGS Based Diagnostics Market Share by Players (2015-2020)
Table 23. Global Top NGS Based Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NGS Based Diagnostics as of 2019)
Table 24. Global NGS Based Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players NGS Based Diagnostics Product Solution and Service
Table 27. Date of Enter into NGS Based Diagnostics Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global NGS Based Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 30. Global NGS Based Diagnostics Market Size Share by Type (2015-2020)
Table 31. Global NGS Based Diagnostics Revenue Market Share by Type (2021-2026)
Table 32. Global NGS Based Diagnostics Market Size Share by Application (2015-2020)
Table 33. Global NGS Based Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 34. Global NGS Based Diagnostics Market Size Share by Application (2021-2026)
Table 35. North America Key Players NGS Based Diagnostics Revenue (2019-2020) (Million US$)
Table 36. North America Key Players NGS Based Diagnostics Market Share (2019-2020)
Table 37. North America NGS Based Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 38. North America NGS Based Diagnostics Market Share by Type (2015-2020)
Table 39. North America NGS Based Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 40. North America NGS Based Diagnostics Market Share by Application (2015-2020)
Table 41. Europe Key Players NGS Based Diagnostics Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players NGS Based Diagnostics Market Share (2019-2020)
Table 43. Europe NGS Based Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 44. Europe NGS Based Diagnostics Market Share by Type (2015-2020)
Table 45. Europe NGS Based Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 46. Europe NGS Based Diagnostics Market Share by Application (2015-2020)
Table 47. China Key Players NGS Based Diagnostics Revenue (2019-2020) (Million US$)
Table 48. China Key Players NGS Based Diagnostics Market Share (2019-2020)
Table 49. China NGS Based Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 50. China NGS Based Diagnostics Market Share by Type (2015-2020)
Table 51. China NGS Based Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 52. China NGS Based Diagnostics Market Share by Application (2015-2020)
Table 53. Japan Key Players NGS Based Diagnostics Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players NGS Based Diagnostics Market Share (2019-2020)
Table 55. Japan NGS Based Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 56. Japan NGS Based Diagnostics Market Share by Type (2015-2020)
Table 57. Japan NGS Based Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 58. Japan NGS Based Diagnostics Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players NGS Based Diagnostics Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players NGS Based Diagnostics Market Share (2019-2020)
Table 61. Southeast Asia NGS Based Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia NGS Based Diagnostics Market Share by Type (2015-2020)
Table 63. Southeast Asia NGS Based Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia NGS Based Diagnostics Market Share by Application (2015-2020)
Table 65. India Key Players NGS Based Diagnostics Revenue (2019-2020) (Million US$)
Table 66. India Key Players NGS Based Diagnostics Market Share (2019-2020)
Table 67. India NGS Based Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 68. India NGS Based Diagnostics Market Share by Type (2015-2020)
Table 69. India NGS Based Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 70. India NGS Based Diagnostics Market Share by Application (2015-2020)
Table 71. Central & South America Key Players NGS Based Diagnostics Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players NGS Based Diagnostics Market Share (2019-2020)
Table 73. Central & South America NGS Based Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America NGS Based Diagnostics Market Share by Type (2015-2020)
Table 75. Central & South America NGS Based Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America NGS Based Diagnostics Market Share by Application (2015-2020)
Table 77. Janssen Company Details
Table 78. Janssen Business Overview
Table 79. Janssen Product
Table 80. Janssen Revenue in NGS Based Diagnostics Business (2015-2020) (Million US$)
Table 81. Janssen Recent Development
Table 82. Roche Company Details
Table 83. Roche Business Overview
Table 84. Roche Product
Table 85. Roche Revenue in NGS Based Diagnostics Business (2015-2020) (Million US$)
Table 86. Roche Recent Development
Table 87. Qiagen Company Details
Table 88. Qiagen Business Overview
Table 89. Qiagen Product
Table 90. Qiagen Revenue in NGS Based Diagnostics Business (2015-2020) (Million US$)
Table 91. Qiagen Recent Development
Table 92. ThermoFisher Scientific Company Details
Table 93. ThermoFisher Scientific Business Overview
Table 94. ThermoFisher Scientific Product
Table 95. ThermoFisher Scientific Revenue in NGS Based Diagnostics Business (2015-2020) (Million US$)
Table 96. ThermoFisher Scientific Recent Development
Table 97. Oxford Gene Technology Company Details
Table 98. Oxford Gene Technology Business Overview
Table 99. Oxford Gene Technology Product
Table 100. Oxford Gene Technology Revenue in NGS Based Diagnostics Business (2015-2020) (Million US$)
Table 101. Oxford Gene Technology Recent Development
Table 102. Illumina Company Details
Table 103. Illumina Business Overview
Table 104. Illumina Product
Table 105. Illumina Revenue in NGS Based Diagnostics Business (2015-2020) (Million US$)
Table 106. Illumina Recent Development
Table 107. Pacific Biosciences Company Details
Table 108. Pacific Biosciences Business Overview
Table 109. Pacific Biosciences Product
Table 110. Pacific Biosciences Revenue in NGS Based Diagnostics Business (2015-2020) (Million US$)
Table 111. Pacific Biosciences Recent Development
Table 112. Paradigm Diagnostics Business Overview
Table 113. Paradigm Diagnostics Product
Table 114. Paradigm Diagnostics Company Details
Table 115. Paradigm Diagnostics Revenue in NGS Based Diagnostics Business (2015-2020) (Million US$)
Table 116. Paradigm Diagnostics Recent Development
Table 117. Innogene Kalbiotech Company Details
Table 118. Innogene Kalbiotech Business Overview
Table 119. Innogene Kalbiotech Product
Table 120. Innogene Kalbiotech Revenue in NGS Based Diagnostics Business (2015-2020) (Million US$)
Table 121. Innogene Kalbiotech Recent Development
Table 122. Admera Health Company Details
Table 123. Admera Health Business Overview
Table 124. Admera Health Product
Table 125. Admera Health Revenue in NGS Based Diagnostics Business (2015-2020) (Million US$)
Table 126. Admera Health Recent Development
Table 127. AITbiotech Company Details
Table 128. AITbiotech Business Overview
Table 129. AITbiotech Product
Table 130. AITbiotech Revenue in NGS Based Diagnostics Business (2015-2020) (Million US$)
Table 131. AITbiotech Recent Development
Table 132. Centogene Company Details
Table 133. Centogene Business Overview
Table 134. Centogene Product
Table 135. Centogene Revenue in NGS Based Diagnostics Business (2015-2020) (Million US$)
Table 136. Centogene Recent Development
Table 137. Phalanx Biotech Group Company Details
Table 138. Phalanx Biotech Group Business Overview
Table 139. Phalanx Biotech Group Product
Table 140. Phalanx Biotech Group Revenue in NGS Based Diagnostics Business (2015-2020) (Million US$)
Table 141. Phalanx Biotech Group Recent Development
Table 142. iGenomX Company Details
Table 143. iGenomX Business Overview
Table 144. iGenomX Product
Table 145. iGenomX Revenue in NGS Based Diagnostics Business (2015-2020) (Million US$)
Table 146. iGenomX Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Global NGS Based Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. DNA Sequencing Features
Figure 3. RNA Sequencing Features
Figure 4. Whole Genome Sequencing Features
Figure 5. Whole Exome Sequencing Features
Figure 6. Other Features
Figure 7. Global NGS Based Diagnostics Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Academics/Research Institutions Case Studies
Figure 11. NGS Based Diagnostics Report Years Considered
Figure 12. Global NGS Based Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global NGS Based Diagnostics Market Share by Regions: 2020 VS 2026
Figure 14. Global NGS Based Diagnostics Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global NGS Based Diagnostics Market Share by Players in 2019
Figure 17. Global Top NGS Based Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NGS Based Diagnostics as of 2019
Figure 18. The Top 10 and 5 Players Market Share by NGS Based Diagnostics Revenue in 2019
Figure 19. North America NGS Based Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe NGS Based Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China NGS Based Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan NGS Based Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia NGS Based Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India NGS Based Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America NGS Based Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
メタゲノムシーケンスの世界市場（～2026年） Metagenomics is the study of genetic material recovered directly from environmental samples. The broad field may also be referred to as environmental genomics, ecogenomics or community genomics. As the price of DNA sequencing continues to fall, metagenomics now allows microbial ecology to be investi…- DNAシーケンシング製品の世界市場（～2026年） DNA sequencing is categorized into first-generation, secondand next-generation, and emerging technologies. Emerging DNA sequencing technologies are cost-effective and offer more rapid and accurate results than other generation technologies. These technologies find application in the areas of diagnos…
- 臨床腫瘍学次世代シーケンシング（NGS）の世界市場（～2026年） NGS allows the testing of all types of variants including single-nucleotide variations, insertions, deletions, exon duplications, gene copy number changes and translocations. The key factor contributing to the growth of the NGS market is the improved understanding of the genetic markers of virulence…
- 免疫レパートリーシーケンスの世界市場（～2026年） Immune Repertoire is the collection of B and T cells with functional diversity in the body that reflects the immune selectivity. Immune Repertoire Sequencing means to sequence the complimentary determining region of both B-cell receptor and T-cell receptor. Immune receptor repertoire profiling portr…
- メタゲノミクスシーケンスの世界市場（～2026年） Metagenomics is the process of cloning and analyzing the genomes of an organism without culturing them in a community. The major factors driving the growth of the global metagenomics market include technological advancements in DNA sequencing. Moreover, metagenomics is applicable across a broad rang…